James Elliott (J W Elliott, J Elliott)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 7

Top Topics

Radiation Therapy

Acute Lymphoblastic Leukemia

Congenital Heart Disease

Top Venues

Veterinary and comparative oncology

Australian veterinary journal

Veterinary medicine and science

This page only lists publications with an associated author ORCID identifier.

Publications

James Elliott, Keith Linder, Michael W Nolan
Feasibility study evaluating arrhythmogenesis and cardiac damage after heart-base irradiation in mice: A brief communication. Veterinary medicine and science 6 (4) (2020)
James Elliott, Jayme Looper, Michele Keyerleber, Michelle Turek, Laura Blackwood, Joshua Henry, Tracy L Gieger
Response and outcome following radiation therapy of macroscopic canine plasma cell tumours. Veterinary and comparative oncology 18 (4) (2020)
James Elliott, S Baines
A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017). Australian veterinary journal 97 (9) (2019)
Katherine Smallwood, Jean-Benoit Tanis, Iain A Grant, Laura Blackwood, David R Killick, Isabel Amores-Fuster, James Elliott, Aran Mas, Aaron Harper, Mary Marrington, Riccardo Finotello
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience. Veterinary and comparative oncology 17 (2) (2019)
James Elliott
Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers. Australian veterinary journal 96 (12) (2018)
James Elliott, R Finotello
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma. Veterinary and comparative oncology 16 (1) (2017)
Elisabetta Treggiari, James Elliott, S J Baines, L Blackwood
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma. Veterinary and comparative oncology 16 (2) (2017)